Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;129(8):85001.
doi: 10.1289/EHP8327. Epub 2021 Aug 26.

Utilizing a Biology-Driven Approach to Map the Exposome in Health and Disease: An Essential Investment to Drive the Next Generation of Environmental Discovery

Affiliations

Utilizing a Biology-Driven Approach to Map the Exposome in Health and Disease: An Essential Investment to Drive the Next Generation of Environmental Discovery

Ming Kei Chung et al. Environ Health Perspect. 2021 Aug.

Abstract

Background: Recent developments in technologies have offered opportunities to measure the exposome with unprecedented accuracy and scale. However, because most investigations have targeted only a few exposures at a time, it is hypothesized that the majority of the environmental determinants of chronic diseases remain unknown.

Objectives: We describe a functional exposome concept and explain how it can leverage existing bioassays and high-resolution mass spectrometry for exploratory study. We discuss how such an approach can address well-known barriers to interpret exposures and present a vision of next-generation exposomics.

Discussion: The exposome is vast. Instead of trying to capture all exposures, we can reduce the complexity by measuring the functional exposome-the totality of the biologically active exposures relevant to disease development-through coupling biochemical receptor-binding assays with affinity purification-mass spectrometry. We claim the idea of capturing exposures with functional biomolecules opens new opportunities to solve critical problems in exposomics, including low-dose detection, unknown annotations, and complex mixtures of exposures. Although novel, biology-based measurement can make use of the existing data processing and bioinformatics pipelines. The functional exposome concept also complements conventional targeted and untargeted approaches for understanding exposure-disease relationships.

Conclusions: Although measurement technology has advanced, critical technological, analytical, and inferential barriers impede the detection of many environmental exposures relevant to chronic-disease etiology. Through biology-driven exposomics, it is possible to simultaneously scale up discovery of these causal environmental factors. https://doi.org/10.1289/EHP8327.

PubMed Disclaimer

Figures

Figure 1 is an illustrated flowchart depicting the study of the exposure and response relationship. The traditional study takes a forward approach from exposure to response. And the biology-based measurement takes a backward approach from response to exposure at the molecular level.
Figure 1.
Approaches to studying the exposure–response relationship. The exposome can be broadly divided into four distinct domains: living environment, socioeconomic factors, lifestyle, and physical-chemical exposures. The effects of exposures can be studied at the ecological, in vivo, in vitro, molecular, and in silico levels. Although exposure and response are heterogeneous, almost all causal biological effects from an exposure are explainable by the underlying molecular connections. To investigate a relationship, traditional study takes a forward approach—from exposure to response. Examples include a hypothesis-driven design with a few predefined exposures and a semi-/fully data-driven design to conduct exploratory studies. In contrast, studies using a biology-based measurement (BBM) approach work differently—from response to exposure—at the molecular level. The bait to capture the exposures can be a few predefined, a particular class, or a broad-scale selection of functional biomolecules. Certain icons in the figure were made by Freepik (www.flaticon.com).
Figure 2 is a set of six illustrations. The first illustration is titled Cohort. It depicts three human stick figures. The second illustration titled Biofluid depicts two test tube icons. The third illustration titled Capture depicts a microplate (each well is coated with one type of receptor) to capture circulating ligands. The fourth illustration titled Elution depicts after incubation, ligands are extracted. The fifth illustration titled Measurement depicts a graph, plotting intensity (y-axis) across time (x-axis). The sixth illustration titled Data presentation depicts three different matrices (lowercase n by feature, lowercase n by the receptor, and receptor by feature) with signals integrating across features or receptors for downstream analyses.
Figure 2.
Using a biology-based measurement approach to characterize the functional exposome. The assay can be implemented in the form of affinity purification–mass spectrometry in six steps. (1) A group of individuals (n) is sampled. (2) Biofluids, such as plasma, are isolated from blood and (3) loaded to the microplate (each well is coated with one type of receptor) to capture circulating ligands. (4) After incubation, ligands are extracted and (5) characterized by mass spectrometry. (6) Data can be presented in three different matrices (n by feature, n by receptor, and receptor by feature) with signals integrating across features or receptors for downstream analyses. A key advantage of this approach is that functional analysis of the exposome is possible without upfront feature identification because molecular exposures are biophysically linked to receptors with known functions. Certain icons in the figure were made by Freepik (www.flaticon.com).
Figure 3 is a four-part illustration with a Venn diagram in the center with arrows pointing to each of the four parts. The Venn diagram has two circles. The left-hand circle is labeled Nature, and the right-hand circle is labeled Nurture. the intersection is labeled Functional exposome. Figure 3A is an illustration titled Sample enrichment that displays two test tubes with an arrow between the two tubes pointing toward the tube on the right. Figure 3B is an illustration titled Functional annotation that displays a graph icon and a tabular representation having two rows and three columns, namely, mass, R T, and Effect. An arrow pointing toward the table is present below the graph icon. Figure 3C is an illustration titled Mixture analysis that displays exposure correlation or shared mode of action, a dot graph, and a stacked bar graph. The stacked bar graph plots exposure (y-axis) across receptor uppercase a and receptor uppercase b (x-axis). There are two arrows pointing toward both the graphs, and it is placed between exposure correlation or shared mode of action and the graphs. Figure 3D is an illustration titled Mapping exposures that displays a database, cloud, and folder icons, and three tabular representations. The first tabular representation has four rows and in five columns, lists Reference F E I D, Mass, Receptor, Identity, and three dots. The second and third tabular representations have three rows and in three columns, lists Mass, Receptor, and three dots, respectively. There are two arrows pointing toward the first table, and these are placed between the three tables.
Figure 3.
Key advantages of using a biology-based measurement approach to study the functional exposome (FE), where nature meets nurture. (A) Enrichment is not required as an extra step but, rather, intrinsically provided by the pull-down assay format. (B) Each detected feature is functionally annotated by the corresponding binding receptors. (C) Health impacts can be assessed in two ways: coexposure correlation or shared mode of action. (D) Each feature can be assigned to a unique reference FE identifier (Ref. FE ID), which is characterized by an accurate mass, the functional molecules (e.g., binding receptors), and other attributes (e.g., mass spectra, detection frequency in the population). The mapping, cataloging, and sharing of exposure information allow unambiguous communication of knowns and unknowns across studies. Certain icons in the figure were made by Freepik (www.flaticon.com). Note: RT, retention time.

Comment in

References

    1. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, et al. . 1991. Complementary DNA sequencing: expressed sequence tags and human genome project. Science 252(5013):1651–1656, PMID: 2047873, 10.1126/science.2047873. - DOI - PubMed
    1. Agier L, Portengen L, Chadeau-Hyam M, Basagaña X, Giorgis-Allemand L, Siroux V, et al. . 2016. A systematic comparison of linear regression–based statistical methods to assess exposome-health associations. Environ Health Perspect 124(12):1848–1856, PMID: 27219331, 10.1289/EHP172. - DOI - PMC - PubMed
    1. Andra SS, Austin C, Patel D, Dolios G, Awawda M, Arora M. 2017. Trends in the application of high-resolution mass spectrometry for human biomonitoring: an analytical primer to studying the environmental chemical space of the human exposome. Environ Int 100:32–61, PMID: 28062070, 10.1016/j.envint.2016.11.026. - DOI - PMC - PubMed
    1. Annis DA, Nickbarg E, Yang X, Ziebell MR, Whitehurst CE. 2007. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery. Curr Opin Chem Biol 11(5):518–526, PMID: 17931956, 10.1016/j.cbpa.2007.07.011. - DOI - PubMed
    1. Balik-Meisner M, Truong L, Scholl EH, La Du JK, Tanguay RL, Reif DM. 2018. Elucidating gene-by-environment interactions associated with differential susceptibility to chemical exposure. Environ Health Perspect 126(6):067010, PMID: 29968567, 10.1289/EHP2662. - DOI - PMC - PubMed

Publication types

LinkOut - more resources